IBM
62
-3
OI
50
-6
SIG
52
5
BK
68
-6
PX
62
6
CCL
64
-4
DUK
52
-2
AVB
30
-2
BDX
60
-4
XEL
39
-2
FTI
60
-18
LH
48
-2
OXY
33
-4
WHR
50
-5
CCI
33
-5
MOS
26
-12
HCA
60
-4
ALL
60
-3
EOG
32
-14
COF
67
2
IBM
62
-3
OI
50
-6
SIG
52
5
BK
68
-6
PX
62
6
CCL
64
-4
DUK
52
-2
AVB
30
-2
BDX
60
-4
XEL
39
-2
FTI
60
-18
LH
48
-2
OXY
33
-4
WHR
50
-5
CCI
33
-5
MOS
26
-12
HCA
60
-4
ALL
60
-3
EOG
32
-14
COF
67
2
Financhill
Back

STF Tactical Growth & Income ETF Vs. Nektar Therapeutics Industry Stock Comparison

Sell
50

TUGN
STF Tactical Growth & Income ETF

Last Price:
$25.08
Seasonality Move:
-2.07%
Sell
42

NKTR
Nektar Therapeutics

Last Price:
$44.64
Seasonality Move:
11.58%
Sell
50
STF Tactical Growth & Income ETF (TUGN) is a Sell

Is STF Tactical Growth & Income ETF a Buy, Sell or Hold?

  • The current STF Tactical Growth & Income ETF [TUGN] share price is $25.41. The Score for TUGN is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
  • TUGN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
42
Nektar Therapeutics (NKTR) is a Sell

Is Nektar Therapeutics a Buy, Sell or Hold?

  • The current Nektar Therapeutics [NKTR] share price is $49.16. The Score for NKTR is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • NKTR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

TUGN Stock Price Chart

What is STF Tactical Growth & Income ETF's stock price today?

  • The STF Tactical Growth & Income ETF share price today is $25.41
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TUGN is experiencing buying pressure, which is a positive indicator for future bullish movement.

NKTR Stock Price Chart

What is Nektar Therapeutics's stock price today?

  • The Nektar Therapeutics share price today is $49.16
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NKTR is experiencing slight buying pressure.

TUGN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.08 Sell
Relative Strength Index (14 RSI): 42.01 Sell
Chaikin Money Flow: 11803 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

NKTR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.43 Sell
Relative Strength Index (14 RSI): 38.92 Sell
Chaikin Money Flow: 341847 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

TUGN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 25.76 Sell
20-day SMA: 25.62 Sell
50-day SMA: 25.96 Sell
200-day SMA: 24.27 Buy
8-day EMA: 25.65 Sell
20-day EMA: 25.74 Sell
50-day EMA: 25.79 Sell
200-day EMA: 24.89 Buy

NKTR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 54.87 Sell
20-day SMA: 57.43 Sell
50-day SMA: 58.05 Sell
200-day SMA: 31.04 Buy
8-day EMA: 54.11 Sell
20-day EMA: 56.28 Sell
50-day EMA: 55.42 Sell
200-day EMA: 38.13 Buy

STF Tactical Growth & Income ETF Earnings Growth & TUGN Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Nektar Therapeutics Earnings Growth & NKTR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.41 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.41 per share, and a decrease next year of $0.27 per share.

STF Tactical Growth & Income ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Nektar Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):